Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
Top Cited Papers
- 23 January 2003
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 421 (6921) , 373-379
- https://doi.org/10.1038/nature01301
Abstract
The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease1. It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice2,3,4,5,6,7. The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to β-sheets containing amyloid fibrils8,9 and can specifically inhibit oligomerization10 and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.Keywords
This publication has 31 references indexed in Scilit:
- Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear InclusionsPublished by Elsevier ,2002
- Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysisProceedings of the National Academy of Sciences, 2001
- Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal CellsJournal of Biological Chemistry, 2000
- Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapyProceedings of the National Academy of Sciences, 2000
- Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formationBiochemical Journal, 1999
- A Model for Structure-Dependent Binding of Congo Red to Alzheimer β-Amyloid FibrilsNeurobiology of Aging, 1998
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Polar zippers: Their role in human diseaseProtein Science, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.Journal of Histochemistry & Cytochemistry, 1989